These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 637670)

  • 1. [Laron type familial dwarfism; genetic primary somatomedin deficiency].
    Pierson M; Malaprade D; Fortier G; Belleville F; Lasbennes A; Wuilbereq L
    Arch Fr Pediatr; 1978 Feb; 35(2):151-64. PubMed ID: 637670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nanism with high values of GH and no generation of somatomedin after hGH (Laron's syndrome). Clinico-biochemical study of 8 cases].
    Ferrández A; Mengual J; Bastaros JC; Gonzalvo N; Laron Z; Silbergeld A
    An Esp Pediatr; 1985 Feb; 22(2):113-22. PubMed ID: 3985503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of blood somatomedin during childhood in normal subjects and in delayed growth].
    Pierson M; Grignon G; Malaprade D; Hartemann P
    Ann Biol Clin (Paris); 1976; 34(1):11-8. PubMed ID: 970694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.
    Kowarski AA; Schneider J; Ben-Galim E; Weldon VV; Daughaday WH
    J Clin Endocrinol Metab; 1978 Aug; 47(2):461-4. PubMed ID: 263308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].
    Mariani P; Gourmelen M; Carnot JF; Saignes F; Cayroche P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1853-6. PubMed ID: 6256891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A child with phenotypic Laron dwarfism and normal somatomedin levels.
    Pintor C; Loche S; Cella SG; Müller EE; Baumann G
    N Engl J Med; 1989 Feb; 320(6):376-9. PubMed ID: 2913494
    [No Abstract]   [Full Text] [Related]  

  • 7. Growth hormone resistance.
    Laron Z; Kowadlo-Silbergeld A; Eshet R; Pertzelan A
    Ann Clin Res; 1980 Oct; 12(5):269-77. PubMed ID: 6263171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early paradoxical decrease in serum somatomedin activity following injection of growth hormone.
    Schimpff RM; Gourmelen M; Donnadieu M; Binoux M; Girard F
    J Clin Endocrinol Metab; 1978 Jan; 46(1):173-6. PubMed ID: 752020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).
    Daughaday WH; Trivedi B
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4636-40. PubMed ID: 3474620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone therapy in short children without classical growth hormone deficiency.
    Bierich JR
    J Endocrinol Invest; 1989; 12(8 Suppl 3):25-33. PubMed ID: 2681346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with hGH. Factors influencing response in children with somatotrophic insufficiency (author's transl)].
    Kurtz F; Mugnier E; Roy MP; Rappaport R
    Arch Fr Pediatr; 1981; 38(6):405-9. PubMed ID: 7294958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
    Laron Z; Klinger B; Erster B; Silbergeld A
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long term responses to hGH in children with idiopathic small-for-dates dwarfism.
    Grunt JA; Enriquez AR; Daughaday WH
    J Clin Endocrinol Metab; 1972 Jul; 35(1):157-68. PubMed ID: 5032510
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of growth hormone binding protein in a normal population and in subjects with short stature due to growth hormone resistance].
    Tar A; Postel-Vinay MC; Brauner R; Rappaport R
    Orv Hetil; 1992 Mar; 133(12):721-2, 727-30. PubMed ID: 1557221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency.
    Lustig RH; Schriock EA; Kaplan SL; Grumbach MM
    Pediatrics; 1985 Aug; 76(2):274-9. PubMed ID: 3927254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and somatomedin-C responses to growth hormone in dwarfed children.
    Hayek A; Peake GT
    J Pediatr; 1981 Dec; 99(6):868-72. PubMed ID: 7198145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prismatic cases: Laron syndrome (primary growth hormone resistance) from patient to laboratory to patient.
    Laron Z
    J Clin Endocrinol Metab; 1995 May; 80(5):1526-31. PubMed ID: 7744997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laron type dwarfism. Study of GH binding protein in 3 cases].
    Aguirre A; Donnadieu M; Job JC; Chaussain JL
    Arch Fr Pediatr; 1991 Jan; 48(1):5-9. PubMed ID: 2018424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dwarfism in the Alagille syndrome caused by somatomedin C deficiency?].
    Blümel P; Sacher M; Paky F; Stögmann W
    Padiatr Padol; 1986; 21(3):257-64. PubMed ID: 3095769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
    Baumann G; Shaw MA; Winter RJ
    J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.